Obesity

Weight loss maintenance with exercise and liraglutide improves glucose tolerance, glucagon response, and beta cell function

Obesity (Silver Spring)Published Randomised controlled trial

Authors' conclusion

Only the combination of exercise and liraglutide improved glucose tolerance, beta cell function, and glucagon responses after weight loss.

Study context

Population
Adults with obesity (BMI 32–43 kg/m²) without diabetes after an 8-week low-calorie diet (800 kcal/d)randomized
Participants
195 adults
Comparison
Exercise, liraglutide 3.0 mg/d, or both combined vs placebo for 52 weeks after diet-induced weight loss
Primary endpoint
Change in glucose and glucagon response to a 3-hour mixed meal test and disposition index (beta cell function)
Follow-up
1 year
Methodological detailsplacebo-controlled
  • Placebo-controlled

Primary result

As reported in the abstract

Postprandial glucose response, beta cell function and glucagon response
Each group vs placeboEstimate (95% CI)P value
Combination
change in postprandial glucose response −9%(−14% to −3%)
P = 0.002
Combination
change in glucagon response −18%(−34% to −3%)
P = 0.024
Liraglutide
change in postprandial glucose response −7%(−12% to −1%)
P = 0.018
Combination · improved
change in beta cell function 49% (95% CI 16%–93%); P = 0.002

Original publication

Weight loss maintenance with exercise and liraglutide improves glucose tolerance, glucagon response, and beta cell function. Obesity (Silver Spring). Published 21 March 2023. doi:10.1002/oby.23715

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.